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Introduction 
Diabetes is a metabolic disorder with an increasing global 
prevalence largely due to population expansion, aging, 
urbanisation, increasing obesity and sedentary lifestyle.1 
According to International Diabetes Federation (IDF) 
estimates, worldwide the number of people with type 2 
diabetes mellitus (T2DM) was 387 million in 2014 with a 
projected rise to 592 million in 2035.2 The greatest 
proportional increase in adults with diabetes is expected 
in low-income and lower middle-income countries 
(LMICs).3 In 2007, more than 110 million people in Asia 
were living with diabetes, with a very high disease load 
among the young. Young age of onset and long disease 
duration puts Asian people with diabetes at high risk for 
cardio-renal complications. Cardiovascular disease (CVD) 
is a serious complication of T2DM that results in 
substantial morbidity, increased mortality and burden on 
healthcare infrastructure.4 
The greater morbidity and mortality from CVD in 
developing countries will have the greatest impact in 
South Asia, which forms nearly a quarter of the total 
global population and where a serious lack of access to 
healthcare also exists. 
Pakistan, an LMIC with a total population of 
approximately 199 million projected population based on 
census figures, has an estimated diabetes prevalence of 
11.4% in the age group of 25 years and above.5 
Few studies from Pakistan have explored the chronic 
complications of diabetes, including CVD.5,6 However, no 
nationwide data exists on cardiovascular complications of 
diabetes. Risk factors for CVD, such as poor glycaemic 
control, smoking, hypertension (HTN) and deranged lipid 
profile, are amenable to intervention which could reduce 
the risk of complications. 
At present, globally the vast majority of people with 
diabetes receive frontline treatment by general 
practitioners (GPs) and family physicians (FPs) rather than 
by specialist endocrinologists.7 The current study was 
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planned to explore risk factors for cardiovascular 
complications of diabetes in people presenting to GP/FP 
clinics across Pakistan. The primary objective was to 
determine the frequency and distribution of the fixed 
(age, gender, ethnicity) and modifiable risk factors 
(glycated haemoglobin [HbA1c] levels, blood pressure 
(BP), lipid profile and smoking status) that contribute to 
CVD risk among diabetics. The secondary objective 
included assessment of absolute risk of a CVD event over 
the next 10 years using current values for all the fixed risk 
factors, and potentially modifiable risk factors like HbA1c 
levels, systolic blood pressure (SBP), high-density 
lipoprotein cholesterol [HDL-C] levels, and smoking 
status, using UK prospective diabetes study (UKPDS) risk 
calculator for CVD risk estimation.8 This will hopefully fill 
the gaps in knowledge that can form the basis for 
effective national prevention programmes targeting this 
population. 
Subjects and Methods 
The cross-sectional, prospective, multicentre, study was 
conducted from June 2014 till July 2015 at family practice 
clinics in 27 cities across Pakistan, and comprised 
individuals aged 30-50 years diagnosed with T2DM in the 
preceding six months.  
Those matching the inclusion criterion consecutively 
presenting at the outpatient clinics of the participating 
centres were screened for the study. Those aged under 30 
years were excluded due to the likelihood of type 1 DM, 
while those aged above 50 years were excluded as age is 
an independent risk factor for CVD and could act as a 
confounder. The eligible participants were enrolled after 
written informed consent. The study was approved by the 
institutional review board of the coordinating centre, 
Shaukat Khanum Memorial Cancer Hospital and Research 
Centre (SKMCH&RC), Lahore, and the National Bioethics 
Committee (NBC), Islamabad, Pakistan. 
Endocrinologists as Regional investigators (RIs) were 
included and they were part of the study steering 
committee that comprised RIs, Principal investigator (PI) 
and co-PIs and was responsible for the study 
questionnaire, design and oversight. Larger 'sample' of 
centres from larger cities was selected to ensure adequate 
representation but it was convenience-based selection as 
per ease of access. We enrolled a selected number of 5 
participants from each clinic. All the participating GPs 
received training on protocol procedures prior to the 
initiation to ensure protocol compliance and uniformity in 
patient selection and data collection across all centres. 
The study questionnaire included the eligibility checklist 
and study variables such as demographic information, 
date of diabetes diagnosis, height, weight, BP 
measurement, smoking and family history etc. Data on 
laboratory variables was collected directly from lab 
reports. Lab investigations were carried out at SKMCH&RC 
and Aga Khan University Hospital (AKUH), Karachi. 
Fasting blood sample with minimum 10-hour fasting was 
collected. Two individuals did the study oversight for data 
queries resolution and data validation at the coordinating 
centre for quality control. 
With an expected proportion of diabetics with high 
cholesterol level being 46%, we aimed for a 95% 
confidence interval (CI) with a sample size of 1000 
participants. Keeping into account 30% expected missing 
data, the target sample was kept at 1300.  
Demographic and baseline characteristics were 
expressed using descriptive statistics. Lab variables to 
normal ranges, as defined by the American Diabetes 
Association (ADA) criteria9 for fasting glucose, HbA1c and 
lipid profile, were compared. Joint National Committee 
(JNC) criteria were used to define HTN and for 
categorisation of BP readings.10,11 Ethnicity specific cut-
offs were used for body mass index (BMI).12 Data was 
analysed using SPSS 19. 
The 10-year absolute risk of fatal or non-fatal coronary 
heart disease (CHD) and stroke was calculated using 
the UKPDS risk engine version 2.0 which is a T2DM-
specific risk calculator based on 53,000 patients' years 
of data.8 
Results 
Of the 1067 participants enrolled, 888(83.2%) comprised 
the study sample. Of them, 362(40.8%) were women and 
526(59.2%) were men.  
In terms of age bifurcation, 612(69%) subjects were ≥40 
years and 276(31.1%) were <39 years. Province-wise, 
534(60.1%), 253(28.5%), 91(10.2%) and, 10(1.1%) were 
residents of Punjab, Sindh, KPK and Balochistan, 
respectively. The vast majority of participants were from 
the city of Karachi 114(12.8%) and Lahore 106(11.9%), 
followed by Faisalabad 56(6.3%), Multan 56(6.3%), 
Peshawar 54(6.1%), Hyderabad 54( 6.1%), Bahawalpur 
52(5.9%), Rawalpindi 46(5.2%), Sukkur 37(4.2%), 
Gujranwala 36(4.1%), Larkana 34(3.8%),  Sahiwal-Okara 
27(3.0%), Gujrat 25(2.8%), Rahim Yar Khan 22(2.5%), 
Sargodha 20(2.3%), Abbottabad 19(2.1%), Sialkot 
19(2.1%), Jhang 17(1.9%), Sheikhupura 15(1.7%), 
Bhakkar & Mianwali 15(1.7%), Mardan 13(1.5%), 
Islamabad 11(1.2%), Bannu-D I Khan 11(1.2%), Quetta 
10(1.1%), Nawabshah 9(1.0%), Toba Tek Singh 5( 0.6%), 
and Khairpur 5(0.6%). 
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As regards ethnicity, 431(48.5%) participants were 
Punjabi, followed by 170(19%) Urdu-speaking, 97(11%) 
Pathan, 81(9%) Saraiki, 74(8.3%) Sindhi, 17(2%) 
mixed/multiracial, 12(1.4%) Kashmiri and 6(0.7%) Balochi 
(Table-1). 
The overall mean presenting age of participants was 
42.4±5.8 years; mean weight was 76±14.1kg; height 
1.7±0.01 meters; BMI 27.8±5.1kg/m2; SBP 
128.1±14.8mmHg; diastolic blood pressure (DBP) 
84.2±9.3mmHg; blood glucose 175.5±83.5mg/dl; HbA1C 
80±6mmol/mol (9.5±2.7%); triglyceride (TG) 
201.6±146.3mg/dl; serum total cholesterol (TC) 
186.2±45.0mg/dl; VLDL 40.4±29.3mg/dl; low-density 
lipoprotein cholesterol (LDL-C) 115.7±36.0mg/dl; HDL-C 
41.2±11.2mg/dl. 
The commonest sub-group for each of the  categorical 
variables under consideration included having a family 
history of diabetes 645(72.6%); not having a family history 
of hypertension 525(59.1%); not having a family history of 
ischaemic heart disease (IHD) 666(75%); not having a 
family history of other diseases 836(94.1%); never having 
smoked 750(84.5%); being obese 621(69.9%); not having 
had atrial fibrillation 594(97.4%); having normal BP 
357(40.2%); having abnormal blood glucose 585(65.9%); 
having HbA1c levels 6.5% or higher 750(84.5%); having 
TG levels within normal range 501(56.4%); having TC 
levels within normal range 570(64.2%); having VLDL levels 
within normal range 498(56.1%); having LDL-C levels 
within normal range 488(55%); and having HDL-C levels 
within normal range 565(63.6%). In addition to 621(70%) 
obese subjects, another 120(13.5%) were overweight. 
Among the 531(60%) with abnormal BP, 192(21.6%) were 
pre-hypertensive, 39(4.4%) had isolated systolic 
hypertension, 122(13.7%) had isolated diastolic 
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Table-1: Characteristics of participants. 
 
Characteristic                                                                                                                    n=888 
 
Age - Mean (Years)                                                                                                          42.42 ± 5.8 
<39 Years, n (%)                                                                                                             276 (31.1%) 
>40 years, n (%)                                                                                                             612 (68.9%) 
Gender                                                                                                                                           
Male, n (%)                                                                                                                        526 (59.2%) 
Female, n (%)                                                                                                                   362 (40.8%) 
Ethnicity, n (%)                                                                                                                          
Punjabi                                                                                                                                431 (48.5%) 
Sindhi                                                                                                                                     74 (8.3%) 
Saraiki                                                                                                                                    81 (9.1%) 
Balochi                                                                                                                                    6 (0.7%) 
Pathan                                                                                                                                  97 (10.9%) 
Kashmiri                                                                                                                                12 (1.4%) 
Urdu Speaking                                                                                                                  170 (19.1%) 
Mixed/Multiracial                                                                                                               17 (1.9%) 
Family history of Type 2 DM, n (%)                                                                                 
Yes                                                                                                                                        645 (72.6%) 
No                                                                                                                                         243 (27.4%) 
Family history of Ischaemic Heart Disease (IHD),  
n (%)                                                                                                                                                  
Yes                                                                                                                                          222 (25%) 
No                                                                                                                                           666 (75%) 
Family history of Hypertension, n (%)                                                                          
Yes                                                                                                                                        363 (40.9%) 
No                                                                                                                                         525 (59.1%) 
Family history of Other Diseases, n (%)                                                                       
Yes                                                                                                                                            3 (0.3%) 
No                                                                                                                                         836 (94.1%) 
Other - Stroke                                                                                                                       8 (0.9%) 
Other - CVA                                                                                                                            4 (0.5%) 
Other - Not Mentioned                                                                                                     35 (3.9%) 
Other - Chronic Severe Asthma                                                                                       2 (0.2%) 
 
Data are expressed as mean ± standard deviation or number (percentage). 
DM: Diabetes mellitus. 
CVA: Cerebrovascular accident.
Table-2: Frequency and Distribution of modifiable risk factors as per sub-categories. 
 
Characteristics           Categories            Frequency 
                                                                    Distribution, n (%) 
 
Body Mass Index (BMI) 
 
 
 
Blood Pressure 
 
 
 
 
 
Fasting Glucose Level 
 
 
 
Glycated haemoglobin 
(HbA1c) 
 
Total Cholesterol 
 
LDL Cholesterol 
 
HDL Cholesterol 
 
 
VLDL 
 
Triglycerides 
 
 
LDL: Low-density lipoprotein 
HDL: High-density lipoprotein 
VLDL: Very low-density lipoprotein.
Under Weight (<18.0 kg/m2) 
Normal BMI (18.0 - 22.9 kg/m2) 
Over Weight (23 - 24.9 kg/m2) 
Obesity (>25 kg/m2) 
Normal BP: (< 120/80) 
Pre-hypertension: (SBP 120-139 by DBP 80-
89) 
SBP <140 by DBP >90 
SBP >140 by DBP <90 
High BP >140 by >90 
Normal (<99mg/dL) 
Impaired fasting Glucose  
(100 - 125 mg/dL) 
Abnormal (>126 mg/dL) 
<39mmol/mol (<5.7%) 
39-46mmol/mol (5.7 - 6.4%) 
>48mmol/mol (>6.5%) 
Within Normal Range (<200mg/dL) 
Above Normal Range (200->240mg/dL) 
Within Normal Range (<100mg/dL) 
Above Normal Range (>100mg/dL) 
Below Normal (<40mg/dL) 
Within Normal Range (40-59mg/dL) 
Above Normal Range (>60mg/dL) 
Within Normal Range (2-30mg/dL) 
Above Normal Range (>30mg/dL) 
Within Normal Range (<150mg/dL) 
Above Normal Range (150->200mg/dL)
10 (1.1%) 
137 (15.4%) 
120 (13.5%) 
621 (69.9%) 
357 (40.2%) 
192 (21.6%) 
 
122 (13.7%) 
39 (4.4%) 
178 (20.0%) 
153 (17.2%) 
150 (16.9%) 
 
585 (65.9%) 
57 (6.4%) 
81 (9.1%) 
750 (84.5%) 
570 (64.2%) 
318 (35.8%) 
488 (55.0%) 
400 (45%) 
309 (34.8%) 
565 (63.6%) 
14 (1.6%) 
498 (56.1%) 
390 (43.9%) 
501 (56.4%) 
387 (43.6%)
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Table-3: Proportional distribution of sub-categories of risk factors associated with cardiovascular disease, by age-group (N=888). 
 
                                                                                                                                                                                                                              Age-category                                                                         
Risk factor                                                                                      < 39 years (n=276) Count (%)                               > 40 years (n=612) Count (%)                              χ2 test, (df), & p-value 
 
Gender                                                                                                                                                                                                                                                                                                            2.4, (1), 0.12 
Male                                                                                                                             174 (63)                                                                              352 (57.5) 
Female                                                                                                                         102 (37)                                                                              260 (42.5) 
Family history of  Type 2 diabetes                                                                                                                                                                                                                                                  3.5, (1), 0.06 
Yes                                                                                                                               212 (76.8)                                                                            433 (70.8) 
No                                                                                                                                 64 (23.2)                                                                              179 (29.2) 
IHD                                                                                                                                                                                                                                                                                                                    0.4, (1), 0.50 
Yes                                                                                                                                73 (26.4)                                                                              149 (24.3) 
No                                                                                                                                203 (73.6)                                                                            463 (75.7) 
Hypertension                                                                                                                                                                                                                                                                                              2.2, (1), 0.13 
Yes                                                                                                                               123 (44.6)                                                                            240 (39.2) 
No                                                                                                                                153 (55.4)                                                                            372 (60.8) 
Other diseases                                                                                                                                                                                                                                                                                            0.9, (1), 0.32 
Yes                                                                                                                                 13 (4.7)                                                                                 39 (6.4) 
No                                                                                                                                263 (95.8)                                                                            573 (93.6) 
Smoking status                                                                                                                                                                                                                                                                                          1.9, (2), 0.36 
Current                                                                                                                        33 (12.0)                                                                               64 (10.5) 
Past                                                                                                                                 9 (3.3)                                                                                   32 (5.2) 
Never                                                                                                                          234 (84.8)                                                                            516 (84.3) 
BMI (kg/m2)                                                                                                                                                                                                                                                                                                 2.1, (3), 0.55 
Under weight (<18.0)                                                                                             4 (1.4)                                                                                    6 (1.0) 
Normal BMI (18.0-22.9)                                                                                        43 (15.6)                                                                               94 (15.4) 
Over weight (23-24.9)                                                                                           31 (11.2)                                                                               89 (14.5) 
Obesity (>25)                                                                                                          198 (71.7)                                                                            423 (69.1) 
Blood pressure (mmHg)                                                                                                                                                                                                                                                                      9.3, (4), 0.054 
Normal BP (< 120/80)                                                                                         126 (45.7)                                                                            231 (37.7) 
Pre HTN (SBP 120-139 by DBP 80-89)                                                              56 (20.3)                                                                              136 (22.2) 
SBP <140 by DBP >90                                                                                          42 (15.2)                                                                               80 (13.1) 
SBP >140 by DBP <90                                                                                            8 (2.9)                                                                                   31 (5.1) 
High BP >140 by >90                                                                                           44 (15.9)                                                                              134 (21.9) 
Atrial fibrillation                                                                                                                                                                                                                                                                                      0.9, (1), 0.32 
Yes                                                                                                                                  5 (1.8)                                                                                   18 (2.9) 
No                                                                                                                                271 (98.2)                                                                            594 (97.4) 
Fasting blood glucose level (mg/dL)                                                                                                                                                                                                                                             2.5, (2), 0.27 
Normal (<99)                                                                                                           46 (16.7)                                                                              107 (17.5) 
Impaired fasting glucose (100-125)                                                                 39 (14.1)                                                                              111 (18.1) 
Abnormal (>126)                                                                                                  191 (69.2)                                                                            394 (64.4) 
Glycated haemoglobin/HbA1c (%)                                                                                                                                                                                                                                                †7.8, (2), 0.02 
<39 mmol/mol (<5.7)                                                                                           26 (9.4)                                                                                 31 (5.1) 
39-46 mmol/mol (5.7-6.4)                                                                                    19 (6.9)                                                                                62 (10.1) 
>48 mmol/mol (>6.5)                                                                                        231 (83.7)                                                                            519 (84.8) 
Fasting total cholesterol (mg/dL)                                                                                                                                                                                                                                                   0.8, (1), 0.35 
Normal (<200)                                                                                                       171 (62.0)                                                                            399 (65.2) 
Above normal (200 to >240)                                                                             105 (38.0)                                                                            213 (34.8) 
LDL-C (mg/dL)                                                                                                                                                                                                                                                                                             0.9, (1), 0.33 
Within normal (100-129)                                                                                    145 (52.5)                                                                            343 (56.0) 
Above normal (130 to >159)                                                                             131 (47.5)                                                                            269 (44.0) 
HDL-C (mg/dL)                                                                                                                                                                                                                                                                                            4.2, (2), 0.12 
Below normal (<40)                                                                                             109 (39.5)                                                                            200 (32.7) 
Normal (40-59)                                                                                                       162 (58.7)                                                                            403 (65.8) 
Above normal (>60)                                                                                                5 (1.8)                                                                                    9 (1.5) 
VLDL (mg/dL)                                                                                                                                                                                                                                                                                           †10.1, (1), 0.001 
Within normal (2-30)                                                                                           133 (48.2)                                                                            365 (59.6) 
Above normal (>30)                                                                                             143 (51.8)                                                                            247 (40.4) 
Triglycerides (mg/dL)                                                                                                                                                                                                                                                                          †7.4, (1), 0.006 
Normal (<150)                                                                                                       137 (49.6)                                                                            364 (59.5) 
Above normal (150 to >200)                                                                             139 (50.4)                                                                            248 (40.5) 
 
IHD: Ischaemic Heart Disease. BMI: Body mass index. HTN: Hypertension. SBP: Systolic blood pressure. DBP: Diastolic blood pressure. LDL: Low-density lipoprotein. HDL: High-density lipoprotein. 
VLDL: Very low-density lipoprotein.
hypertension and 178(20%) had hypertension. 
Analyses of blood glucose levels and HbA1c were also 
done (Table-2). 
Those aged >40 years were significantly associated with 
higher HbA1c (p=0.02) and those aged <39 years were 
significantly associated with higher levels of VLDL 
(p=0.001) and TG (p=0.006). Other associations were not 
statistically significant (Table-3). 
Mean risk estimate for CHD was 9.7% (CI: 9.0-10.1), fatal 
CHD 4.4% (CI: 4.0-4.6), stroke 1.5% (CI: 1.2-1.7), and fatal 
stroke 0.25% (CI: 0.22-0.24) (Figure). 
Discussion 
Diabetes adds to the CVD risk, and the National 
Cholesterol Education Programme (NCEP) categorises 
diabetes as CVD equivalent.13 Most of the cardiovascular 
risk factors like dyslipidaemia, hypertension, obesity and 
glucose intolerance co-exist in people with T2DM which 
increases their risk of CVD.14 
Number of men in our study was more compared to the 
number of women. Number of participants in age group 
40-49 years was more compared to those younger than 
40 years. A younger age of onset is seen in a developing 
country15 which puts this population at a higher risk of 
developing complications of 
diabetes due to longer 
hyperglycaemic exposure.16 
Participants belonging to 
Punjabi ethnicity were more 
common in our study perhaps 
due to a large number of cities 
included from the province of 
Punjab which is the most 
populated province of the 
country.17 
Familial clustering of T2DM is 
well-known and is high in 
South Asians.18 Similarly, in our 
study almost two-thirds of the 
participants had family history 
for diabetes in first-degree 
relatives. Family history of IHD 
in first-degree relatives is also a 
risk factor for the development 
of IHD or CVD.19 In our study 
25% participants had a family 
history of IHD. 
Smoking is a strong risk factor 
for developing CVD, especially 
amongst people with diabetes.20 The prevalence of 
smoking in our study was lower (15%) and similar to 
earlier studies done in Pakistan16,20 which indicates a 
reporting bias. 
The mean BMI of our study population was 27.76 kg/m2, 
which does not fulfil obesity criteria from the developed 
world (>30kg/m2).21 Studies suggest that for a given BMI, 
South Asians have more visceral fat than Western 
population which increases metabolic risk associated 
with obesity.22 When we used ethnicity-specific criteria11 
to define obesity (BMI>25kg/m2), we found 70% obese 
patients in the study. South Asians are considered to be at 
risk of developing obesity-related co-morbidities at lower 
levels of BMI and waist circumference.11 The higher 
prevalence of obesity may probably be one of the reasons 
for the study population developing diabetes at an early 
age. The findings of the current study are consistent with 
another cross-sectional study from Karachi which 
reported 68% prevalence of obesity.16 A nationwide study 
from India involving 4600 newly-diagnosed T2DM people 
reported 26% prevalence of obesity.23 
Mean HbA1C was 80±6mmol/mol (9.5 ± 2.71%) in the 
present study. Though only participants with confirmed 
T2DM diagnosis were included, 6% participants had an 
HbA1c <5.7% and another 9% had HbA1c in the pre-
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Figure: Mean ten-year risk estimates for cardiovascular disease as assessed by UKPDS risk calculator. 
Lines represent mean risk for non-fatal and fatal coronary heart disease (CHD), fatal coronary heart disease (fatal CHD), non-fatal 
and fatal stroke (stroke) and fatal stroke. Confidence intervals are shown as error bars.
diabetes range of 5.7-6.4%. Considering that participants 
enrolled were recently diagnosed with T2DM, it is quite 
likely an effect of lifestyle modification resulting in a 
better glycaemic control in some participants, or it was 
too early for HbA1C to have started rising. HbA1C 
compared in two-sub groups (A: 30-39 years; B: 40-49 
years) revealed higher HbA1C in group B, and this 
difference was statistically significant. This represents 
poor long-term control of blood sugar or possible delay in 
diagnoses. Fasting blood glucose is altered in people with 
diabetes, but in the present study, 17.2% had normal 
fasting glucose, 16.9% and 65.9% had impaired and 
abnormal fasting glucose, respectively. Possible 
explanations are improvement in glycaemic control by 
lifestyle modification or abnormalities of post-prandial 
glucose levels only. 
People with diabetes are more likely to have atherogenic 
dyslipidaemia which is characterised by TGs, raised small 
dense LDL (sdLDL), elevated VLDL and decreased HDL-C 
levels.24 The current study found that >40% participants 
had dyslipidaemia wherein the prevalence of elevated TC, 
elevated LDL-C and VLDL were seen in 43.9%, 45% and 
43.9% participants respectively. Low HDL-C was seen in 
34.8% participants and 43.6% had elevated TG. It is quite 
likely that some of the patients had >1 lipid abnormalities. 
A higher prevalence of dyslipidaemia is an important 
finding as the presence of dyslipidaemia in people with 
T2DM would increase the risk of CVD by 3-4 folds 
compared to people without diabetes having 
dyslipidaemia.25 Furthermore, ~50% participants in the 
younger age group (<39 years) had higher VLDL and TG 
levels compared to the older age group (>40 years), 
indicating a higher prevalence of dyslipidaemia in the 
younger age group. Lower HDL-C levels and higher TG 
levels were seen in South Asians compared to British 
population in the UK.16 
Hypertension is well- recognised as an independent risk 
factor for the development of CVD. This risk increases 
further when it is associated with diabetes.14 The mean 
SBP and DBP was 128.08±4.76mmHg and 84.23±9.28 
mmHg which was slightly higher than normal and similar 
to that reported by an earlier study that reported a higher 
SBP and DBP in South Asians compared to Caucasians.16 
Out of all participants enrolled, 38% had hypertension, 
defined as SBP >140 mmHg and/or DBP >90 mmHg. A 
local study reported 42% prevalence of HTN in people 
with T2DM (20). The JNC 7 guide for the management of 
HTN reported that amongst those older than age 50, SBP 
>140mmHg is a more significant determinant of CVD risk 
than DBP. Pre-hypertension individuals (SBP 120-
139mmHg or DBP 80-90mmHg) should be advised on 
lifestyle modification to prevent the progressive risk in BP 
to decrease risk of CVD.26 
The current study used the UKPDS risk engine to assess 
10-year absolute risk of CVD. The strength of the engine is 
that it can address multiple aspects of cardiovascular 
disease risk27 with a higher applicability to high-risk 
cohorts of diabetes. UKPDS risk engine is intended for use 
in adults who have T2DM, no previous heart disease or 
strokes, white Afro-Caribbean or Asian-Indian ethnic 
background and no serious life-threatening illness such as 
cancer.12 Limitations of UKPDS risk engine have been 
described since the model was derived from people 
recruited for a randomised controlled trial and so was 
limited to people eligible for the study.28 A study among 
Australian diabetics29 compared UKPDS and Framingham 
cardiovascular risk equation and found UKPDS calculator 
to be suitable only for stroke risk prediction in this 
population alluding to need for ethnicity-specific 
calculators. In comparison with QRISK2 (a cardiovascular 
disease risk algorithm based on data from QRESEARCH 
database), the UKPDS calculator is considered to be more 
specific to patients with T2DM, highlighting that risk 
estimations amongst persons with diabetes differ from 
healthy individuals.30 
As in any cross-sectional study, selection and recall bias 
exists in the current study which is its limitation. Data on 
lifestyle and educational status of the participants was not 
collected, which are associated with CVD risk. 
Participating centres were from 27 larger cities of Pakistan 
and it may not be appropriate to generalise the findings 
to the rural population. The study used convenience-
based sampling, which can impact sample 
representativeness. 
Conclusion 
CVD and diabetes are amongst the commonest non-
communicable diseases in Pakistan associated with major 
morbidity, mortality and burden on healthcare 
infrastructure. To the best of our knowledge this is the 
largest study to assess CVD risk amongst people with 
T2DM. Data also highlights the need of screening for 
cardiovascular risk factors in younger age group with 
newly diagnosed T2DM. Ethnicity-specific thresholds are 
needed for BMI, indicating the need for national 
consensus guidelines. Public health programmes 
addressing risk factors for CVD that are amenable to 
intervention through lifestyle modification are needed. 
Disclaimer: The study was presented at the following 
meetings: Updates on Diabetes / Diabetes Quiz: During 
2nd Cardiometabolic Conference: Tokyo Japan. May 17, 
2017; Diabetes and Cardiovascular Risk: Finding of CardiP 
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Trial, Invited talk and oral presentation during annual 
meeting of Pakistan Endocrine Society, Islamabad. Nov 
19, 2016; CardiP Trial: Cardiovascular Disease and 
Diabetes: At AACE Symposium during summer retreat of 
Pakistan Endocrine Society. May 29 -30, 2015. PC Bhurbon 
, Pakistan; and Double trouble-Tackling Cardiovascular 
risk in diabetic subjects: During Plenary session at 2nd 
Annual Symposium of South Asian Federation of 
Endocrine Societies (SAFES) meeting in Dhaka, 
Bangladesh. April 24, 2015. 
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